Navigation Links
LCA-Vision Announces Termination of Consent Solicitation and Withdrawal of Dissident Slate of Director Nominees
Date:3/30/2009

CINCINNATI, March 30 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus(R) brand, today announced that, according to a March 26, 2009 filing with the Securities and Exchange Commission, the dissident Joffe Group announced it has terminated its solicitation of written consents from LCA-Vision stockholders and that the Group has disbanded. Additionally, the Joffe Group stated that it has withdrawn its slate of Board of Director nominees for election at the LCA-Vision 2009 Annual Meeting. As of March 26, 2009, other than its own votes, the Joffe Group received votes totaling 6% of LCA-Vision's outstanding shares.

"We appreciate the support we received from our stockholders, surgeons, optometrists and staff during the consent solicitation process and are happy to put this matter behind us," said Steven Straus, LCA-Vision chief executive officer. "We are now able to focus 100% of our attention on our business, working closely with our Medical Advisory Board, Optometric Advisory Board, surgeons, optometrists and all LCA-Vision / LasikPlus(R) staff members to manage through challenging economic times and prepare for future success."

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 75 LasikPlus(R) fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

Earning Trust Every Moment.


'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. RiskMetrics Affirms Recommendation that Stockholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
2. LCA-Visions Medical Advisory Board Voices Support for Current Management
3. Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors
4. LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually
5. The LCA-Vision Full Value Committee Urges LCA-Vision (NASDAQ: LCAV) Stockholders to Reject the Status Quo
6. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
7. LCA-Vision to Present at the Raymond James 30th Annual Institutional Investors Conference
8. Glass Lewis Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Three Proposals by Dissident Joffe Group
9. The LCA-Vision Full Value Committee Files Detailed Presentations
10. LCA-Vision Reports Tangible Results from Business Strategy
11. LCA-Vision Announces Appointment of Edgar F. Heizer to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...
(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...
(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...
(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...
(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...
Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5Health News:Residency match results not encouraging for adults needing primary care 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3
... York, NY -- A JDRF collaboration between Johns Hopkins ... the treatment of diabetic eye disease has performed better ... laser surgery. , These findings, representing the six-month ... The Johns Hopkins University, were presented Monday at the ...
... perhaps more importantly, who should be charged with the ... , Elisa Hurley, a philosophy professor, is seeking answers ... The University of Western Ontario. , In the Academy ... fictional, non-surgical procedure called targeted memory erasure is used ...
... Manual released today, SAN DIEGO, April 29 ... Updated and Expanded Edition, by Michael,Roizen, MD, and Mehmet ... HarperCollins in 2005, sold more than 2.5 million copies ... in 2005. The new,edition, packed with tons of new ...
... liquidity to selling shareholders, opportunities for buyer to, ... communications franchise, NEW YORK, April 29 ... Media Associates in its sale to HMP,Communications, a ... continue to have an investment in the new ...
... AVIV, Israel, April 29 Elbit Imaging Ltd.,(the "Company") ... informed by,Aurora Fidelity Trust Company Ltd., the trustee for ... of the Company (the "Trustee" and the "Notes",respectively), that ... the,two accounting firms, Zohar, Zohar & Co., the controlling ...
... key to stopping infection , , TUESDAY, April 29 (HealthDay News) ... on the virus itself, but new research suggests that focusing ... , That,s because human cells mutate at much slower rates ... chance of mutating around the drug, scientists explained. , The ...
Other Medicine News:Health News:Promising early evidence of the superior benefits of drug therapy for diabetic eye disease 2Health News:Moral philosopher questions memory manipulation 2Health News:America's Favorite Doctors Try to Outdo Their Own Blockbuster 2Health News:Berkery Noyes Represents Princeton Media Associates in Its Sale to HMP Communications/Alta 2Health News:Berkery Noyes Represents Princeton Media Associates in Its Sale to HMP Communications/Alta 3Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 2Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 3Health News:Researchers Tackle HIV From a New Angle 2Health News:Researchers Tackle HIV From a New Angle 3
(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...
(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...
(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...
Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3Exposure to lead tobacco smoke raises risk of ADHD 10856 1Exposure to lead tobacco smoke raises risk of ADHD 10856 2Measuring and modeling blood flow in malaria 61892 1Measuring and modeling blood flow in malaria 61892 2
... in Nature Medicine, WHITE PLAINS, N.Y., July 28 ... a serious and potentially deadly,disorder that affects about 5 ... may have important implications for diagnosis,and treatment in humans., ... Ph.D., Department of,Biochemistry and Molecular Biology; and Susan M. ...
... Cells, RARITAN, N.J., July 25 An ... tumor cells (CTCs) is a,strong indicator of progression-free ... to a report published in the July 1,issue ... study, conducted in the US, the Netherlands, and ...
Other Medicine Technology:New Research on Pre-Eclampsia in Mice May Have Important Implications for Humans 2Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer 2Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer 3
... The SYNCHRON CX5-S workstation offers ... testing, targeted to the mid-size ... 200 samples per day. Like ... CX5-S is easy to use, ...
... capacity of 57 assays and ... tests, the CX1000 PRO system ... you can maximize your time, ... The CX1000 PRO creates a ...
... user-friendly instrument is the ... analyzer for the medium ... a well established nephelometric ... for a wide range ...
... By using multi-channel catheters ... and/or proximal esophagus, the catheter-based pH test ... from a pharmaceutical agent) in the stomach ... relation to ENT or pulmonary symptoms. Ability ...
Medicine Products: